QA software could reduce misdiagnosis
This article was originally published in Clinica
UK researchers have developed a software security interface designed to reduce the risk of misdiagnosis caused by sub-standard digital image displays. The team, from the Leeds Teaching Hospital NHS trust, is now seeking a commercial partner to take the product to market.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.